This inventor holds 1 USPTO granted patent. Top assignee: Guangzhou Hanfang Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Yukang Mao in Cancer Treatment
Introduction
Yukang Mao is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of medicine, particularly in the development of treatments for cancer-related fatigue. His innovative approach has led to the creation of a unique patent that addresses a critical need in cancer care.
Latest Patents
Yukang Mao holds a patent for "spore oil and use thereof in preparation of anti-cancer-related fatigue medicaments." This invention involves spore oil, which contains a triglyceride content greater than 90% and is free from detectable triterpenoids. The extraction process utilizes supercritical CO2, followed by elution with a silica gel column and a mixed solution of petroleum ether-ethyl acetate. The resulting spore oil is concentrated under reduced pressure and vacuum-dried. This oil has shown high effectiveness in mitigating cancer-related fatigue, demonstrating good safety and potential for use in medicaments aimed at treating this condition.
Career Highlights
Yukang Mao is associated with Guangzhou Hanfang Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical field. His work is characterized by a commitment to improving the quality of life for cancer patients through effective treatment options.
Collaborations
Yukang has collaborated with notable colleagues, including Lin Cao and Qin Zhang, to further advance research and development in his field. Their combined expertise contributes to the success of their projects and the impact of their innovations.
Conclusion
Yukang Mao's contributions to cancer treatment through his patented spore oil exemplify the importance of innovation in medicine. His work not only addresses a significant health issue but also showcases the potential of natural compounds in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile